Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early detection of amyloid load using 18F-florbetaben PET.
Bullich S, Roé-Vellvé N, Marquié M, Landau SM, Barthel H, Villemagne VL, Sanabria Á, Tartari JP, Sotolongo-Grau O, Doré V, Koglin N, Müller A, Perrotin A, Jovalekic A, De Santi S, Tárraga L, Stephens AW, Rowe CC, Sabri O, Seibyl JP, Boada M. Bullich S, et al. Among authors: jovalekic a. Alzheimers Res Ther. 2021 Mar 27;13(1):67. doi: 10.1186/s13195-021-00807-6. Alzheimers Res Ther. 2021. PMID: 33773598 Free PMC article.
Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease.
Sabbagh MN, Schäuble B, Anand K, Richards D, Murayama S, Akatsu H, Takao M, Rowe CC, Masters CL, Barthel H, Gertz HJ, Peters O, Rasgon N, Jovalekic A, Sabri O, Schulz-Schaeffer WJ, Seibyl J. Sabbagh MN, et al. Among authors: jovalekic a. J Alzheimers Dis. 2017;56(2):441-446. doi: 10.3233/JAD-160821. J Alzheimers Dis. 2017. PMID: 27983552 Clinical Trial.
Added value of 18F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study.
Ceccaldi M, Jonveaux T, Verger A, Krolak-Salmon P, Houzard C, Godefroy O, Shields T, Perrotin A, Gismondi R, Bullich S, Jovalekic A, Raffa N, Pasquier F, Semah F, Dubois B, Habert MO, Wallon D, Chastan M, Payoux P; NEUUS in AD study group; Stephens A, Guedj E. Ceccaldi M, et al. Among authors: jovalekic a. Alzheimers Dement. 2018 Mar;14(3):293-305. doi: 10.1016/j.jalz.2017.09.009. Epub 2017 Nov 4. Alzheimers Dement. 2018. PMID: 29107051 Free article. Clinical Trial.
New protein deposition tracers in the pipeline.
Jovalekic A, Koglin N, Mueller A, Stephens AW. Jovalekic A, et al. EJNMMI Radiopharm Chem. 2017;1(1):11. doi: 10.1186/s41181-016-0015-3. Epub 2016 Jun 2. EJNMMI Radiopharm Chem. 2017. PMID: 29564387 Free PMC article. Review.
Evaluation of tau deposition using 18F-PI-2620 PET in MCI and early AD subjects-a MissionAD tau sub-study.
Bullich S, Mueller A, De Santi S, Koglin N, Krause S, Kaplow J, Kanekiyo M, Roé-Vellvé N, Perrotin A, Jovalekic A, Scott D, Gee M, Stephens A, Irizarry M. Bullich S, et al. Among authors: jovalekic a. Alzheimers Res Ther. 2022 Jul 27;14(1):105. doi: 10.1186/s13195-022-01048-x. Alzheimers Res Ther. 2022. PMID: 35897078 Free PMC article. Clinical Trial.
Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods.
Jovalekic A, Roé-Vellvé N, Koglin N, Quintana ML, Nelson A, Diemling M, Lilja J, Gómez-González JP, Doré V, Bourgeat P, Whittington A, Gunn R, Stephens AW, Bullich S. Jovalekic A, et al. Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3276-3289. doi: 10.1007/s00259-023-06279-0. Epub 2023 Jun 10. Eur J Nucl Med Mol Imaging. 2023. PMID: 37300571 Free PMC article.
16 results